Stocks News

LAST PRICE
1.2100
TODAY'S CHANGE (%)
Trending Down-0.0100 (-0.8197%)

Bid / Lots
1.1700/ 7
Ask / Lots
1.2400/ 100
Open / Previous Close
1.2200 / 1.2200
Day Range
Low 1.1800
High 1.2300
52 Week Range
Low 1.0000
High 2.2299
Volume
43,131
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Today
- Co-Diagnostics, Inc. to Host Booth at MEDICA Trade Fair in Düsseldorf, Germany on Nov 11-14, 2024, from 9 hours ago by PR Newswire
  9 hours ago by PR Newswire
  Companies Mentioned: CODX
  Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be hosting a booth and delivering a presentation at the MEDICA 2024 trade fair in Düsseldorf, Germany on November 11-14.
- Co-Diagnostics, Inc. to Host Booth at MEDICA Trade Fair in D sseldorf, Germany on Nov 11-14, 2024, from 9 hours ago by Dow Jones
  9 hours ago by Dow Jones
  Companies Mentioned: CODX
  
  Co-Diagnostics, Inc. to Host Booth at MEDICA Trade Fair in Düsseldorf, Germany on Nov 11-14, 2024
  
  PR Newswire
  
  SALT LAKE CITY, Nov. 5, 2024
Oct 25, 2024
- Co-Diagnostics, Inc. Announces Third Quarter 2024 Earnings Release Date and Webcast, from 4:01PM ET on Friday Oct 25, 2024 by PR Newswire
  4:01PM ET on Friday Oct 25, 2024 by PR Newswire
  Companies Mentioned: CODX
  Co-Diagnostics, Inc.(NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its third quarter 2024 results on Thursday, November 7, 2024, after the market close. The Company will also host a conference call and webcast on the same day at 4:30 p.m. ET to discuss its financial results with analysts and institutional investors. Management on the call will include Dwight Egan, Chief Executive Officer, Brian Brown, Chief Financial Officer, and Andrew Benson, Head of Investor Relations.
- Co-Diagnostics, Inc. Announces Third Quarter 2024 Earnings Release Date and Webcast, from 4:01PM ET on Friday Oct 25, 2024 by Dow Jones
  4:01PM ET on Friday Oct 25, 2024 by Dow Jones
  Companies Mentioned: CODX
  
  Co-Diagnostics, Inc. Announces Third Quarter 2024 Earnings Release Date and Webcast
  
  PR Newswire
  
  SALT LAKE CITY, Oct. 25, 2024
  
  SALT LAKE CITY, Oct. 25, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its third quarter 2024 results on Thursday, November 7, 2024, after the market close. The Company will also host a conference call and webcast on the same day at 4:30 p.m. ET to discuss its financial results with analysts and institutional investors. Management on the call will include Dwight Egan, Chief Executive Officer, Brian Brown, Chief Financial Officer, and Andrew Benson, Head of Investor Relations.
Oct 21, 2024
- Co-Diagnostics, Inc. to Host Booth at Medlab Africa in Cape Town on Oct 22-24, 2024, from 9:30AM ET on Monday Oct 21, 2024 by PR Newswire
  9:30AM ET on Monday Oct 21, 2024 by PR Newswire
  Companies Mentioned: CODX
  Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that Co-Diagnostics will be hosting a booth at Africa Health/Medlab Africa in Cape Town, South Africa on October 22-24, 2024.

Today
- *DJ IceCure Medical Offering Up to 22.2M Shrs With Accompanying Warrants, from 2 hours ago by Dow Jones
  2 hours ago by Dow Jones
  Companies Mentioned: ICCM
- T2 Biosystems to Report Third Quarter 2024 Financial Results and Business Updates on November 14, 2024, from 11 hours ago by Dow Jones
  11 hours ago by Dow Jones
  Companies Mentioned: TTOO
Oct 31, 2024
- NeuroOne(R) Announces Expansion of Existing Distribution Agreement with Zimmer Biomet for Commercialization of OneRF(TM) Ablation System, from 4:01PM ET on Thursday Oct 31, 2024 by Dow Jones
  4:01PM ET on Thursday Oct 31, 2024 by Dow Jones
  Companies Mentioned: NMTC
Oct 29, 2024
- Upcoming FDA Advisory Panel for IceCure's ProSense(R) Marketing Authorization Receives Large Number of Public Comments from Stakeholders, from 8:30AM ET on Tuesday Oct 29, 2024 by PR Newswire
  8:30AM ET on Tuesday Oct 29, 2024 by PR Newswire
  Companies Mentioned: ICCM
- Upcoming FDA Advisory Panel for IceCure's ProSense(R) Marketing Authorization Receives Large Number of Public Comments from Stakeholders, from 8:30AM ET on Tuesday Oct 29, 2024 by Dow Jones
  8:30AM ET on Tuesday Oct 29, 2024 by Dow Jones
  Companies Mentioned: ICCM
Oct 24, 2024
- NeuroOne(R) Medical Technologies to Present at the 2024 ThinkEquity Conference, from 9:00AM ET on Thursday Oct 24, 2024 by Dow Jones
  9:00AM ET on Thursday Oct 24, 2024 by Dow Jones
  Companies Mentioned: NMTC
Oct 21, 2024
- IceCure Receives Notice of Allowance from U.S. Patent and Trademark Office for its Next-Generation Cryoablation System, from 8:30AM ET on Monday Oct 21, 2024 by PR Newswire
  8:30AM ET on Monday Oct 21, 2024 by PR Newswire
  Companies Mentioned: ICCM
- IceCure Receives Notice of Allowance from U.S. Patent and Trademark Office for its Next-Generation Cryoablation System, from 8:30AM ET on Monday Oct 21, 2024 by Dow Jones
  8:30AM ET on Monday Oct 21, 2024 by Dow Jones
  Companies Mentioned: ICCM
Oct 15, 2024
- *DJ IceCure Medical Offering Shares and Warrants, from 4:28PM ET on Tuesday Oct 15, 2024 by Dow Jones
  4:28PM ET on Tuesday Oct 15, 2024 by Dow Jones
  Companies Mentioned: ICCM
Oct 8, 2024
- T2 Biosystems to Host Business Update Call on October 10, 2024, from 4:05PM ET on Tuesday Oct 08, 2024 by Dow Jones
  4:05PM ET on Tuesday Oct 08, 2024 by Dow Jones
  Companies Mentioned: TTOO

Co-Diagnostics Inc
NASDAQ:CODXUnited States

Search Criteria

Today

Co-Diagnostics, Inc. to Host Booth at MEDICA Trade Fair in Düsseldorf, Germany on Nov 11-14, 2024, from 9 hours ago by PR Newswire

Co-Diagnostics, Inc. to Host Booth at MEDICA Trade Fair in D sseldorf, Germany on Nov 11-14, 2024, from 9 hours ago by Dow Jones

Oct 25, 2024

Co-Diagnostics, Inc. Announces Third Quarter 2024 Earnings Release Date and Webcast, from 4:01PM ET on Friday Oct 25, 2024 by PR Newswire

Co-Diagnostics, Inc. Announces Third Quarter 2024 Earnings Release Date and Webcast, from 4:01PM ET on Friday Oct 25, 2024 by Dow Jones

Oct 21, 2024

Co-Diagnostics, Inc. to Host Booth at Medlab Africa in Cape Town on Oct 22-24, 2024, from 9:30AM ET on Monday Oct 21, 2024 by PR Newswire

Peers Headlines

Today

*DJ IceCure Medical Offering Up to 22.2M Shrs With Accompanying Warrants, from 2 hours ago by Dow Jones

T2 Biosystems to Report Third Quarter 2024 Financial Results and Business Updates on November 14, 2024, from 11 hours ago by Dow Jones

Oct 31, 2024

NeuroOne(R) Announces Expansion of Existing Distribution Agreement with Zimmer Biomet for Commercialization of OneRF(TM) Ablation System, from 4:01PM ET on Thursday Oct 31, 2024 by Dow Jones

Oct 29, 2024

Upcoming FDA Advisory Panel for IceCure's ProSense(R) Marketing Authorization Receives Large Number of Public Comments from Stakeholders, from 8:30AM ET on Tuesday Oct 29, 2024 by PR Newswire

Upcoming FDA Advisory Panel for IceCure's ProSense(R) Marketing Authorization Receives Large Number of Public Comments from Stakeholders, from 8:30AM ET on Tuesday Oct 29, 2024 by Dow Jones

Oct 24, 2024

NeuroOne(R) Medical Technologies to Present at the 2024 ThinkEquity Conference, from 9:00AM ET on Thursday Oct 24, 2024 by Dow Jones

Oct 21, 2024

IceCure Receives Notice of Allowance from U.S. Patent and Trademark Office for its Next-Generation Cryoablation System, from 8:30AM ET on Monday Oct 21, 2024 by PR Newswire

IceCure Receives Notice of Allowance from U.S. Patent and Trademark Office for its Next-Generation Cryoablation System, from 8:30AM ET on Monday Oct 21, 2024 by Dow Jones

Oct 15, 2024

*DJ IceCure Medical Offering Shares and Warrants, from 4:28PM ET on Tuesday Oct 15, 2024 by Dow Jones

Oct 8, 2024

T2 Biosystems to Host Business Update Call on October 10, 2024, from 4:05PM ET on Tuesday Oct 08, 2024 by Dow Jones